Dental Implant

Brand Name : Straumann

Model Name / Code : BLT, Ø 4.1mm RC, SLA® 8mm, Ti, Loxim™

Manufacturer : Straumann group

Compare

EGP2,800.00

Sold By : Straumann-Egypt
No ratings found yet!
Contact Vendor

Product Description

Titanium SLA Implant

Item Name Dental Implant
Brand Name Straumann
Model Name / Code BLT, Ø 4.1mm RC, SLA® 8mm, Ti, Loxim™
Manufacturer Straumann group
Country of origin Switzerland
Technical Specifications Implant Category: Implants / Implant Line: Bone Level Implants / Material: Titanium / Procedure: Non-guided / Endosteal Length: 8 mm / Implant Platform: Regular CrossFit® Ø 4.1 mm / Surface: SLA® / Endosteal Diameter: Ø 4.1 mm / Transfer piece: Loxim®
Package 1 Unit
Variations
Manufacture Date 2020
Expiry Date 2024
Guarantee terms Life Time
Remarks Order Code: 021.5408

There are no reviews yet.

Be the first to review “Dental Implant”

Vendor Information

Straumann
NC Healing abutment - conical shape, Ø 3.6mm, H 5mm, Ti
Straumann group
(0)

Excellent Esthetic Outcomes – Through the soft tissue management by a transgingival, semi-submerged or submerged healing procedure.

Straumann
RC Healing abutment - conical shape, Ø 6mm, H 6mm, Ti
Straumann group
(0)

Excellent Esthetic Outcomes – Through the soft tissue management by a transgingival, semi-submerged or submerged healing procedure.

Straumann
BL, Ø 3.3mm NC, SLActive® 12mm, Roxolid®
Straumann group
(0)

SLActive®️ is Straumann’s high performance surface with extensive healing potential. It stands for high predictability and accelerated osseointegration. Recent studies show an outstanding clinical performance of SLActive®️ implants even in very challenging treatment protocols and patients with compromised health.

Straumann
SP, Ø 3.3mm NNC, SLActive® 12mm, Roxolid®
Straumann group
(0)

SLActive®️ is Straumann’s high performance surface with extensive healing potential. It stands for high predictability and accelerated osseointegration. Recent studies show an outstanding clinical performance of SLActive®️ implants even in very challenging treatment protocols and patients with compromised health.

Product Enquiry